| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-president, MD | MD & Co-president
1 company
Navid Mahmoodzadegan is Co-president, MD at MC. Navid Mahmoodzadegan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.1M at current prices.
Our model assigns Navid Mahmoodzadegan a below-average insider score of 48/100, based on 13 past trades. Over a 12-month horizon, 15.4% of those trades were profitable, with an average 12-month return of -22.5%.
The MC filings lean toward selling, a net 2,165,979 shares.
Navid Mahmoodzadegan has 63 Form 4 filings on record from March 2017 to February 2026, all as Chief Executive Officer at Moelis & (MC), 2017–2026.
The 201 reported transactions were 141 option or other derivative awards, 28 open-market sales, 16 option exercises and 10 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $90.1M.
The largest open-market sale was 1,195,848 shares of MC at an average $38.55 on October 27, 2020, about $46.1M.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | MC Moelis & Co | Co-president, MD | Sale+OE | 9,406 | $74.00 | $696,044.00 | -4.5% | -22.6% | -19.3% | |
| May 13, 2024 | MC Moelis & Co | Co-president, MD | Sell | 44,980 | $54.92 | $2,470,301.60 | -100% | +9.2% | +11.1% | |
| Mar 1, 2024 | MC Moelis & Co | Co-president, MD | Sell | 70,255 | $54.05 | $3,797,016.96 | -61.0% | +5.2% | +31.9% | |
| Feb 22, 2024 | MC Moelis & Co | Co-president, MD | Sale+OE | 96,302 | $52.85 | $5,089,617.84 | -45.5% | +3.9% | +28.3% | |
| Feb 21, 2024 | MC Moelis & Co | Co-president, MD | Sell | 65,954 | $55.26 | $3,644,807.48 | -66.0% | +5.7% | +34.3% | |
| Mar 3, 2023 | MC Moelis & Co | Co-president, MD | Sell | 23,323 | $43.05 | $1,004,055.15 | -18.9% | -11.6% | +24.3% | |
| Mar 1, 2023 | MC Moelis & Co | Co-president, MD | Sell | 106,218 | $43.17 | $4,585,881.15 | -46.3% | -9.8% | +25.9% | |
| Feb 22, 2023 | MC Moelis & Co | Co-president, MD | Sale+OE | 68,561 | $42.06 | $2,883,675.66 | -23.0% | -12.5% | +28.3% | |
| Feb 22, 2022 | MC Moelis & Co | Co-president, MD | Sale+OE | 53,518 | $47.12 | $2,521,768.16 | -26.9% | -5.8% | -5.7% | |
| Oct 27, 2020 | MC Moelis & Co | Co-president, MD | Sale+OE | 1,195,848 | $38.55 | $46,099,940.40 | - | - | - |